$IONS
IONIS PHARMACEUTICALS INC

2019 Q2 Form 10-Q Financial Statement

#000114036119014492 Filed on August 08, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 Q2
Revenue $163.8M $117.7M
YoY Change 39.12% 4.85%
Cost Of Revenue $1.364M $0.00
YoY Change
Gross Profit $162.4M $117.7M
YoY Change 37.96%
Gross Profit Margin 99.17% 100.0%
Selling, General & Admin $75.11M $66.20M
YoY Change 13.46% 196.85%
% of Gross Profit 46.24% 56.22%
Research & Development $106.2M $101.8M
YoY Change 4.32% 21.92%
% of Gross Profit 65.37% 86.46%
Depreciation & Amortization $3.600M $3.000M
YoY Change 20.0% 25.0%
% of Gross Profit 2.22% 2.55%
Operating Expenses $75.11M $66.20M
YoY Change 13.46% -37.43%
Operating Profit -$18.83M -$50.28M
YoY Change -62.56%
Interest Expense $11.80M $11.11M
YoY Change 6.2% -218.22%
% of Operating Profit
Other Income/Expense, Net -$45.00K $45.00K
YoY Change -200.0% -55.0%
Pretax Income -$16.94M -$56.21M
YoY Change -69.87% 1838.34%
Income Tax -$6.900M $400.0K
% Of Pretax Income
Net Earnings -$876.0K -$40.36M
YoY Change -97.83% 1201.87%
Net Earnings / Revenue -0.53% -34.28%
Basic Earnings Per Share -$0.01 -$0.29
Diluted Earnings Per Share -$0.01 -$0.29
COMMON SHARES
Basic Shares Outstanding 140.2M 128.7M
Diluted Shares Outstanding 140.2M 128.7M

Balance Sheet

Concept 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.262B $1.981B
YoY Change 14.22% 131.45%
Cash & Equivalents $272.5M $805.5M
Short-Term Investments $1.990B $1.175B
Other Short-Term Assets $102.1M $77.00M
YoY Change 32.56% 49.51%
Inventory $18.50M $9.100M
Prepaid Expenses
Receivables $31.60M $16.80M
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.414B $2.083B
YoY Change 15.88% 116.02%
LONG-TERM ASSETS
Property, Plant & Equipment $135.3M $127.9M
YoY Change 5.82% 28.28%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $25.78M $12.70M
YoY Change 102.98% 135.19%
Total Long-Term Assets $463.5M $164.0M
YoY Change 182.65% 29.75%
TOTAL ASSETS
Total Short-Term Assets $2.414B $2.083B
Total Long-Term Assets $463.5M $164.0M
Total Assets $2.878B $2.247B
YoY Change 28.05% 106.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.63M $13.30M
YoY Change 17.5% 0.0%
Accrued Expenses $49.68M $73.60M
YoY Change -32.5% 59.31%
Deferred Revenue $137.4M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $12.50M $1.200M
YoY Change 941.67% -94.42%
Total Short-Term Liabilities $241.2M $248.6M
YoY Change -2.97% 29.61%
LONG-TERM LIABILITIES
Long-Term Debt $647.0M $624.7M
YoY Change 3.57% 7.21%
Other Long-Term Liabilities $532.4M $556.6M
YoY Change -4.35% 452.18%
Total Long-Term Liabilities $1.179B $1.181B
YoY Change -0.16% 72.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $241.2M $248.6M
Total Long-Term Liabilities $1.179B $1.181B
Total Liabilities $1.421B $1.551B
YoY Change -8.42% 77.21%
SHAREHOLDERS EQUITY
Retained Earnings -$883.7M
YoY Change
Common Stock $2.177B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.269B $696.3M
YoY Change
Total Liabilities & Shareholders Equity $2.878B $2.247B
YoY Change 28.05% 106.02%

Cashflow Statement

Concept 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income -$876.0K -$40.36M
YoY Change -97.83% 1201.87%
Depreciation, Depletion And Amortization $3.600M $3.000M
YoY Change 20.0% 25.0%
Cash From Operating Activities -$27.10M $500.2M
YoY Change -105.42% 21647.83%
INVESTING ACTIVITIES
Capital Expenditures -$4.000M -$6.700M
YoY Change -40.3% 6.35%
Acquisitions
YoY Change
Other Investing Activities -$106.7M -$368.5M
YoY Change -71.04% -1863.16%
Cash From Investing Activities -$110.7M -$375.2M
YoY Change -70.5% -2652.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 34.50M 452.9M
YoY Change -92.38% 25061.11%
NET CHANGE
Cash From Operating Activities -27.10M 500.2M
Cash From Investing Activities -110.7M -375.2M
Cash From Financing Activities 34.50M 452.9M
Net Change In Cash -103.3M 577.9M
YoY Change -117.88% 2973.94%
FREE CASH FLOW
Cash From Operating Activities -$27.10M $500.2M
Capital Expenditures -$4.000M -$6.700M
Free Cash Flow -$23.10M $506.9M
YoY Change -104.56% 5794.19%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Interest Expense
InterestExpense
23402000
CY2018Q2 ions Research Development And Patent Expense
ResearchDevelopmentAndPatentExpense
101830000
ions Research Development And Patent Expense
ResearchDevelopmentAndPatentExpense
212582000
ions Research Development And Patent Expense
ResearchDevelopmentAndPatentExpense
205897000
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
75111000
CY2018Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
66198000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
143332000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
109851000
dei Entity Registrant Name
EntityRegistrantName
IONIS PHARMACEUTICALS INC
dei Entity Central Index Key
EntityCentralIndexKey
0000874015
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
ions Period After Billing When Payment Is Received
PeriodAfterBillingWhenPaymentIsReceived
P3M
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-19125
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0336973
dei Entity Address Address Line1
EntityAddressAddressLine1
2855 Gazelle Court
dei Entity Address City Or Town
EntityAddressCityOrTown
Carlsbad
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92010
dei City Area Code
CityAreaCode
760
dei Local Phone Number
LocalPhoneNumber
931-9200
dei Security12b Title
Security12bTitle
Common Stock, $.001 Par Value
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Trading Symbol
TradingSymbol
IONS
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
1989508000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
1805252000
CY2019Q2 us-gaap Investment Income Net
InvestmentIncomeNet
13735000
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
117747000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
262165000
CY2019Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1364000
CY2018Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2406000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0
CY2019Q2 ions Research Development And Patent Expense
ResearchDevelopmentAndPatentExpense
106165000
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
168028000
us-gaap Costs And Expenses
CostsAndExpenses
358320000
us-gaap Costs And Expenses
CostsAndExpenses
315748000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-18827000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
163813000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-50281000
us-gaap Operating Income Loss
OperatingIncomeLoss
102706000
us-gaap Operating Income Loss
OperatingIncomeLoss
-53583000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-45000
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
45000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-192000
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-123000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
140247000
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
128712000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
139419000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
127030000
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-10012000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6927000
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
358000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24119000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
372000
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-10012000
CY2018Q2 us-gaap Profit Loss
ProfitLoss
-56570000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-9136000
CY2018Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-14663000
CY2018Q2 us-gaap Profit Loss
ProfitLoss
-56570000
us-gaap Profit Loss
ProfitLoss
80873000
us-gaap Profit Loss
ProfitLoss
-67381000
CY2019Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-9136000
CY2018Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-16215000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2694000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-25606000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-876000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-40355000
us-gaap Net Income Loss
NetIncomeLoss
83567000
us-gaap Net Income Loss
NetIncomeLoss
-41775000
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
88637000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-68256000
ions Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
1035000
ions Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
0
us-gaap Profit Loss
ProfitLoss
80873000
us-gaap Profit Loss
ProfitLoss
-67381000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
14436000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
17661000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
16364000
ions Revenue From Contract With Customer Number Of Performance Obligations At Inception Of Contract
RevenueFromContractWithCustomerNumberOfPerformanceObligationsAtInceptionOfContract
1
CY2019Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
46900000
CY2018Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-37932000
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
128712000
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.29
CY2018Q4 ions Long Term Obligations Noncurrent
LongTermObligationsNoncurrent
4914000
CY2019Q2 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
276360000
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
290796000
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
14432000
CY2018Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
13749000
CY2019Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
586797000
CY2018Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
568215000
CY2019Q2 ions Long Term Obligations Noncurrent
LongTermObligationsNoncurrent
16091000
CY2018Q2 us-gaap Investment Income Net
InvestmentIncomeNet
5137000
CY2019Q2 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
59878000
CY2018Q4 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
59842000
CY2019Q2 us-gaap Liabilities
Liabilities
1420563000
CY2018Q4 us-gaap Liabilities
Liabilities
1480624000
us-gaap Investment Income Net
InvestmentIncomeNet
25880000
us-gaap Investment Income Net
InvestmentIncomeNet
8748000
CY2019Q2 us-gaap Interest Expense
InterestExpense
11802000
CY2018Q2 us-gaap Interest Expense
InterestExpense
11113000
us-gaap Interest Expense
InterestExpense
22051000
us-gaap Profit Loss
ProfitLoss
80873000
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
140000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
138000
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2177222000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2047250000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-24252000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-32016000
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-883726000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-967293000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
1269384000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1048079000
CY2019Q2 us-gaap Minority Interest
MinorityInterest
187818000
CY2018Q4 us-gaap Minority Interest
MinorityInterest
139081000
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1457202000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1187160000
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2877765000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2667784000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
461026000
us-gaap Profit Loss
ProfitLoss
-67381000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
7775000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-967000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-11000
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
140500298
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
92000
CY2018Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
387101000
CY2018Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
447965000
CY2018Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
2912000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
415000
us-gaap Inventory Write Down
InventoryWriteDown
0
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-933000
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
140247000
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
ions Incremental Common Shares Attributable To Employee Stock Purchase Plan
IncrementalCommonSharesAttributableToEmployeeStockPurchasePlan
8000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
86628000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-38530000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
127030000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
272523000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
805490000
us-gaap Interest Paid Net
InterestPaidNet
4776000
us-gaap Interest Paid Net
InterestPaidNet
4753000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
13920000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
ions Non Cash Capital And Patent Expenditures
NonCashCapitalAndPatentExpenditures
3073000
ions Non Cash Capital And Patent Expenditures
NonCashCapitalAndPatentExpenditures
2645000
ions Payments To Acquire Licenses And Other Assets
PaymentsToAcquireLicensesAndOtherAssets
2310000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6297000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
675860000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
278820000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
129630000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-6656000
CY2018Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-55970000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-16939000
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-56212000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
104992000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-67009000
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.29
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.61
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
140247000
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
128712000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
142499000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
127030000
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
182640000
CY2018Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
37000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
33876000
CY2018Q2 us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
-14663000
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
817436000
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1387420000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-876000
CY2019Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
3452000
CY2019Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-96000
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
34943000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
41933000
CY2018Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
33300000
CY2019Q2 ions Cost Of Products Sold Previously Recognized
CostOfProductsSoldPreviouslyRecognized
200000
ions Cost Of Products Sold Previously Recognized
CostOfProductsSoldPreviouslyRecognized
300000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2696000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-24062000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
91333000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-44194000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-40355000
CY2018Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
563000
CY2019Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
438000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2019Q2 us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
-9136000
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1457202000
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
365280000
us-gaap Net Income Loss
NetIncomeLoss
-41775000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-967000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
92000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
447965000
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
8576000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
62327000
us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
-24062000
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
817436000
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1187160000
us-gaap Net Income Loss
NetIncomeLoss
83567000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
7775000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-11000
us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
102004000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
87437000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
8034000
us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
-2696000
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1457202000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
203000
ions Increase Decrease In Accrued And Deferred Liabilities
IncreaseDecreaseInAccruedAndDeferredLiabilities
3283000
ions Increase Decrease In Accrued And Deferred Liabilities
IncreaseDecreaseInAccruedAndDeferredLiabilities
-8218000
ions Payments To Acquire Licenses And Other Assets
PaymentsToAcquireLicensesAndOtherAssets
1854000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
447965000
us-gaap Use Of Estimates
UseOfEstimates
<div style="display:none;"><br/></div> <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Use of Estimates</div> <div style="display:none;"><br/></div> <div style="text-align: justify; text-indent: 36pt;"><span style="font-size: 12pt; font-family: 'Times New Roman';"><br/></span></div> <div style="display:none;"><br/></div> <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</div>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6900000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
87200000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
62000000.0
CY2019Q2 ions Number Of Privately Held Companies In Which Entity Has Equity Investment
NumberOfPrivatelyHeldCompaniesInWhichEntityHasEquityInvestment
4
CY2019Q2 us-gaap Inventory Net
InventoryNet
18500000
CY2018Q4 us-gaap Inventory Net
InventoryNet
8600000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
86628000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
139419000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
86628000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
139419000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
142499000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.61
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
182640000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-18827000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
461026000
us-gaap Costs And Expenses
CostsAndExpenses
358320000
us-gaap Costs And Expenses
CostsAndExpenses
315748000
us-gaap Operating Income Loss
OperatingIncomeLoss
-53583000
CY2019Q2 us-gaap Assets
Assets
2877765000
us-gaap Operating Income Loss
OperatingIncomeLoss
102706000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
262165000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
163813000
CY2019Q2 ions Available For Sale Securities Debt Maturities After One Through Two Years Percentage
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughTwoYearsPercentage
0.19
ions Maximum Contract Maturity Period Range2
MaximumContractMaturityPeriodRange2
P2Y
ions Maximum Contract Maturity Period Range3
MaximumContractMaturityPeriodRange3
P3Y
ions Maximum Contract Maturity Period Range1
MaximumContractMaturityPeriodRange1
P1Y
CY2019Q2 ions Available For Sale Securities Debt Maturities Within One Year Percentage
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearPercentage
0.76
ions Maximum Contract Maturity Period Range1
MaximumContractMaturityPeriodRange1
P1Y
ions Maximum Contract Maturity Period Range2
MaximumContractMaturityPeriodRange2
P2Y
CY2019Q2 ions Available For Sale Securities Debt Maturities After Two Through Three Years Percentage
AvailableForSaleSecuritiesDebtMaturitiesAfterTwoThroughThreeYearsPercentage
0.05
CY2019Q2 ions Available For Sale Securities Debt Maturities Total Percentage
AvailableForSaleSecuritiesDebtMaturitiesTotalPercentage
1
CY2019Q2 ions Available For Sale Securities Debt Maturities Within Two Years Percentage
AvailableForSaleSecuritiesDebtMaturitiesWithinTwoYearsPercentage
0.95
ions Maximum Contract Maturity Period Range2
MaximumContractMaturityPeriodRange2
P2Y
CY2019Q2 ions Number Of Privately Held Companies In Which Entity Has Equity Investment
NumberOfPrivatelyHeldCompaniesInWhichEntityHasEquityInvestment
4
CY2019Q2 ions Number Of Publicly Held Companies In Which Entity Has Equity Investment
NumberOfPubliclyHeldCompaniesInWhichEntityHasEquityInvestment
2
CY2019Q2 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
1212000
us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
0
us-gaap Equity Securities Fv Ni Unrealized Loss
EquitySecuritiesFvNiUnrealizedLoss
316000
CY2019Q2 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
896000
CY2019Q2 ions Debt Securities Available For Sale And Equity Securities Fv Ni Cost
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFvNiCost
2012084000
CY2019Q2 ions Debt Securities Available For Sale And Equity Securities Fv Ni Gross Unrealized Gain
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFvNiGrossUnrealizedGain
4868000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24100000
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
117747000
CY2018Q2 us-gaap Costs And Expenses
CostsAndExpenses
168028000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-50281000
CY2018Q4 us-gaap Assets
Assets
2667784000
CY2019Q2 ions Debt Securities Available For Sale And Equity Securities Fv Ni Gross Unrealized Loss
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFvNiGrossUnrealizedLoss
1028000
CY2019Q2 ions Debt Securities Available For Sale And Equity Securities Fv Ni
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFvNi
2015924000
CY2018Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
1212000
CY2018 us-gaap Equity Securities Fv Ni Unrealized Gain
EquitySecuritiesFvNiUnrealizedGain
137000
CY2018 us-gaap Equity Securities Fv Ni Unrealized Loss
EquitySecuritiesFvNiUnrealizedLoss
0
CY2018Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
1349000
CY2018Q4 ions Debt Securities Available For Sale And Equity Securities Fv Ni Cost
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFvNiCost
1874529000
CY2018Q4 ions Debt Securities Available For Sale And Equity Securities Fv Ni Gross Unrealized Gain
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFvNiGrossUnrealizedGain
556000
CY2018Q4 ions Debt Securities Available For Sale And Equity Securities Fv Ni Gross Unrealized Loss
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFvNiGrossUnrealizedLoss
4068000
CY2018Q4 ions Debt Securities Available For Sale And Equity Securities Fv Ni
DebtSecuritiesAvailableForSaleAndEquitySecuritiesFvNi
1871017000
CY2019Q2 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1
185
CY2019Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
476280000
CY2019Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
434000
CY2019Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
106806000
CY2019Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
278000
CY2019Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
583086000
CY2019Q2 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
712000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2855000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2607000
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12900000
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
17700000
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y8M12D
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.076
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1900000
us-gaap Operating Lease Payments
OperatingLeasePayments
2000000.0
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1548000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3124000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2505000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
11861000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
24500000
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6823000
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
17677000
CY2019Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
1000000.0
CY2018Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
900000
us-gaap Operating Lease Expense
OperatingLeaseExpense
1900000
us-gaap Operating Lease Expense
OperatingLeaseExpense
900000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
400000
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
400000

Files In Submission

Name View Source Status
0001140361-19-014492-index-headers.html Edgar Link pending
0001140361-19-014492-index.html Edgar Link pending
0001140361-19-014492.txt Edgar Link pending
0001140361-19-014492-xbrl.zip Edgar Link pending
ex10_1.htm Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
form10q_htm.xml Edgar Link completed
ions-20190630.xsd Edgar Link pending
ions-20190630_cal.xml Edgar Link unprocessable
ions-20190630_def.xml Edgar Link unprocessable
ions-20190630_lab.xml Edgar Link unprocessable
ions-20190630_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending